Combination activity of eribulin liposomal formulation and anti-PD-1 antibody after tumor regrowth during anti-PD-1 antibody treatment in mice

被引：0
|
作者：
Tamura, Moe
Niwa, Yuki
Semba, Taro
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-5260
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5260
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Anti-PD-1 antibody treatment for melanoma
    Ribas, Antoni
    Kirkwood, John M.
    Flaherty, Keith T.
    LANCET ONCOLOGY, 2018, 19 (05): : E219 - E219
  • [2] Anti-PD-1 antibody treatment for melanoma Reply
    Beaver, Julia A.
    Keegan, Patricia
    Lemery, Steven
    Pazdur, Richard
    Theoret, Marc R.
    LANCET ONCOLOGY, 2018, 19 (05): : E220 - E220
  • [3] Liposome-Encapsulated Eribulin Shows Enhanced Antitumor Activity over Eribulin for Combination Therapy with Anti-PD-1 Antibody
    Niwa, Yuki
    Adachi, Keito
    Tabata, Kimiyo
    Ishida, Ryoga
    Hotta, Koichiro
    Ishida, Tomomi
    Mano, Yuji
    Ozawa, Yoichi
    Minoshima, Yukinori
    Funahashi, Yasuhiro
    Semba, Taro
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (04) : 499 - 510
  • [4] Combination Foretinib and Anti-PD-1 Antibody Immunotherapy for Colorectal Carcinoma
    Fu, Yuyin
    Peng, Yujia
    Zhao, Shengyan
    Mou, Jun
    Zeng, Lishi
    Jiang, Xiaohua
    Yang, Chengli
    Huang, Cheng
    Li, Yuyan
    Lu, Yin
    Wu, Mengdan
    Yang, Yanfang
    Kong, Ting
    Lai, Qinhuai
    Wu, Yangping
    Yao, Yuqin
    Wang, Yuxi
    Gou, Lantu
    Yang, Jinliang
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [5] Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment
    Hiro Sato
    Noriyuki Okonogi
    Takashi Nakano
    International Journal of Clinical Oncology, 2020, 25 : 801 - 809
  • [6] Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment
    Sato, Hiro
    Okonogi, Noriyuki
    Nakano, Takashi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (05) : 801 - 809
  • [7] Anti-PD-1 monoclonal antibody Cancer immunotherapy
    da Silva, R. Moreira
    DRUGS OF THE FUTURE, 2014, 39 (01) : 15 - 24
  • [8] Psoriasiform lesions induced by anti-PD-1 antibody
    Li-wen Zhang
    Yan Li
    Li-xin Fu
    Yong-hong Lu
    Tao Chen
    Rong-hua Xu
    European Journal of Dermatology, 2023, 33 : 179 - 181
  • [9] Agranulocytosis under Anti-PD-1 Antibody Therapy
    Gellrich, F. F.
    Meier, F.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 78 - 79
  • [10] Psoriasiform lesions induced by anti-PD-1 antibody
    Zhang, Li-wen
    Li, Yan
    Fu, Li-xin
    Lu, Yong-hong
    Chen, Tao
    Xu, Rong-hua
    EUROPEAN JOURNAL OF DERMATOLOGY, 2023, 33 (02) : 179 - 181
12345